ArticleJournal of epidemiology and global health2014
Cardiovascular disease research output in WHO priority areas between 2002 and 2011.
Article in Journal of epidemiology and global health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Analysis and prediction of research hotspots and trends in heart failure research.Journal of translational internal medicine · 2024Article
- Mortality and Discharge Outcome in Acute Myocardial Infarction Patients: A Study Based on Korean National Hospital Discharge In-Depth Injury Survey Data.Risk management and healthcare policy · 2024Article
- Global Cardiovascular Research: Gaps and Opportunities.Current cardiology reports · 2023Review
- A score appraising Paleolithic diet and the risk of cardiovascular disease in a Mediterranean prospective cohort.European journal of nutrition · 2022Article
- Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction.Cardiovascular diabetology · 2022Article
- Identifying knowledge gaps in heart failure research among women using unsupervised machine-learning methods.Future cardiology · 2021Article
- Role of Outer Membrane Vesicles FromFrontiers in cell and developmental biology · 2021Article
- Hot topics and trends in cardiovascular research.European heart journal · 2019Article
- Validation of the Brazilian Version of CADE-Q II to Assess Knowledge of Coronary Artery Disease Patients.Arquivos brasileiros de cardiologia · 2019Article
- Development and Psychometric Validation of HIPER-Q to Assess Knowledge of Hypertensive Patients in Cardiac Rehabilitation.Arquivos brasileiros de cardiologia · 2018Article
- Association of blood glucose and lipid levels with complete blood count indices to establish a regression model.Biomedical reports · 2017Article
- Article
- Learning lessons from operational research in infectious diseases: can the same model be used for noncommunicable diseases in developing countries?Advances in medical education and practice · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Approximately 17.3 million people died from cardiovascular disease (CVD) in 2008, and approximately 80% came from low- and middle-income countries. However, previous studies document poor research productivity related to CVD prevention and treatment in these countries between 1991 and 1996. The World Health Organization (WHO) developed a prioritized research agenda emphasizing research on policy development, translation of knowledge and implementation. This study assessed whether research output in priority areas increased between 2002 and 2011. It was reported that only 3-4% of papers from each year related to a priority area, and most were conducted by corresponding authors from high-income countries. Low-income countries were highly underrepresented both in terms of productivity and as the study population. However, there was a significant rise in the productivity of middle-income countries and their representation as the study population. While 30% of priority-related papers addressed a cost-effective strategy, this represents 1% of papers overall. More cost-effectiveness research is encouraged to decrease the millions of deaths per year attributed to CVD in the developing world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.